BioMed

BioMed is an international, peer-reviewed, open access journal, aims to provide a publishing platform that covers the broad field of subjects in biology and medicine. BioMed is published quarterly online by MDPI.
  • Open Access—free to download, share, and reuse content. Authors receive recognition for their contribution when the paper is reused.
  • Rapid Publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 36.3 days after submission; acceptance to publication is undertaken in 17.3 days (median values for papers published in this journal in the first half of 2021).
  • Recognition of Reviewers: APC discount vouchers, optional signed peer review, and reviewer names published annually in the journal.
  • BioMed is a companion journal of Biomedicines.
Add your e-mail address to receive forthcoming issues of this journal:
Topic in Biomedicines, BioMed, Reports
Photodynamic Therapy Editor-in-Chief: Stefano Bacci
Deadline: 31 December 2021
Topic in BioMed, Biomedicines, CIMB, Neurology International
Bioactive Natural Products and Synthetic Small Molecules as Potential Investigational Treatments for Neurodegenerative Diseases Editor-in-Chief: Wen-Chi Hou
Deadline: 31 January 2022
Topic in IJMS, Biomedicines, Life, BioMed, Reprod. Med.
Pathogenesis of Pregnancy-Related Complications Editors-in-Chief: Ilona Hromadnikova, Katerina Kotlabova
Deadline: 28 February 2022
Topic in Biomedicines, Reports, CIMB, BioMed, Diagnostics
Cancer Biology and Therapy Editor-in-Chief: Massimo Moro
Deadline: 31 March 2022
Special Issue in BioMed
New Trends in Plastic Surgery: From Substitutive Surgery to the Regenerative Surgery Guest Editor: Pietro Gentile
Deadline: 31 December 2021
Back to TopTop